PTC Therapeutics Announces FDA Grants Priority Review to Risdiplam for the Treatment of Spinal Muscular Atrophy November 26, 2019
Longwood-Founded Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform November 21, 2019
Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines November 20, 2019
Axial Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial Evaluating AB-2004 in Patients with Autism Spectrum Disorder November 18, 2019
Millendo Completes Patient Recruitment for Pivotal Study of Livoletide in Prader-Willi Syndrome November 14, 2019
Millendo Reports Third Quarter 2019 Operating and Financial Results; Livoletide pivotal study in PWS completed recruitment and is on track to report topline results in 1H20; Nevanimibe Phase 2b study in CAH continues recruitment, topline results expected November 14, 2019
